By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Level 1, 39 Leveson Street

North Melbourne  Victoria  3051  Australia
Phone: 61-3-9018-4880 Fax: 61-3-9018-4881



Company News
Immuron Commences U.S. Non-Deal Institutional Investor Roadshow 8/15/2017 10:33:09 AM
Immuron CEO Thomas Liquard Resigns 8/3/2017 6:37:50 AM
Immuron Release: NASH Phase II Interim Analysis Reveals Improvement In Liver Enzymes (AST And ALT) With Good Safety And Tolerability 7/10/2017 10:16:51 AM
Immuron Announces Pricing Of U.S. Initial Public Offering And NASDAQ Listing – Raising US $6.1 Million 6/9/2017 10:28:21 AM
Immuron Announces Positive Results Of IMM-124E In Acute Colitis Research Studies 4/19/2017 10:42:46 AM
Immuron Completes Phase II NASH Clinical Trial Recruitment 2/21/2017 10:09:38 AM
Immuron Significantly Rerated By European/US Analyst's Report 2/15/2017 7:36:54 AM
Immuron Announces First Patient Enrolled In Pediatric Fatty-Liver Phase II Trial 2/7/2017 7:27:12 AM
Immuron (ASX:IMC) Announces First USA Orders For Travelan 4/20/2015 9:05:08 AM
Immuron Signs Agreement To Sell Travelan In China 2/17/2015 7:59:53 AM